Kory James Wentworth, CFO: Entrada Therapeutics TRDA Sell · Filed 25/03/19

Trade details

Type: Insider sale
Amount: $19,035.28
Shares · price: 1,784 sh · $10.67 a share
Held after: 109,536 sh
Stock: Entrada Therapeutics TRDA
Person: Kory James WentworthCFO
Trade date: 25/03/17
Filed: 25/03/19
Days to filing: 2 days

Sold 1.6% of holdings

Share of holding sold: 1.6%

Entrada Therapeutics trades, last 26 weeks

What else happened in Entrada Therapeutics around then

Filed or reported within 30 days of the trade day · 25/02/15~25/04/16

Kory James Wentworth's recent trades

Kory James WentworthCFO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$32.4K
2,500 sh
$32.4K
Filed 04/02
Traded 04/01
Kory James WentworthCFO
Planned sale10b5-1 planEntrada Therapeutics
Planned sale10b5-1 plan
Entrada Therapeutics
TRDA
$31.6K
2,500 sh
$31.6K
Filed 04/01
Traded 04/01
Kory James WentworthCFO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$148.3K
11,388 sh
$148.3K
Filed 03/11
Traded 03/10
Kory James WentworthCFO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$66.2K
5,089 sh
$66.2K
Filed 03/11
Traded 03/09
Kory James WentworthCFO
Planned sale10b5-1 planEntrada Therapeutics
Planned sale10b5-1 plan
Entrada Therapeutics
TRDA
$207.3K
16,477 sh
$207.3K
Filed 03/09
Traded 03/09

Kory James Wentworth, CFO — sold $19K of Entrada Therapeutics TRDA · 1.6% of holdings · 10b5-1 plan | Whalegun